Le Lézard
Classified in: Health

Local Organization NOVA ScriptsCentral Benefits BIG with Eli Lilly release of Bulk Donation Insulin Pens


FAIRFAX, Va., Feb. 27, 2020 /PRNewswire-PRWeb/ -- Lilly, a leading biopharmaceutical company based in Indianapolis, is providing bulk donations of insulin KwikPens® ( Humalog, Humalog 75/25 & Basaglar) to NOVA ScriptsCentral through Direct Relief. In 2018 NOVA ScriptsCentral (NSC) was selected by Lilly to be one of the first pilot sites in the country through Direct Relief to receive bulk insulin vial donations, NOVA ScriptsCentral has been dispensing Lilly insulin vial products to its patients. This gave patients who are not eligible for pharma patient assistance programs access to much needed insulin.

Many of the patients NSC serves are the working poor who work multiple jobs and suffer from a variety of medical conditions, one of which is diabetes. They struggle with managing traditional insulin vial regimens because of their hectic work schedules which make it difficult for them to administer their insulin doses. NSC can now offer a 30 - 90 days supply of insulin KwikPens® prescriptions to patients for $5 through multiple partner clinics across Northern Virginia. By now having access this will allow these individuals more flexibility to administer insulin doses while balancing their work schedules.

Lilly is the first insulin manufacturer to make insulin pens available through a bulk donation program adding to their established offering of insulin vials. Lilly announced in January it will donate 200,000 KwikPens to relief over the next three years.

Executive Director of NOVA ScriptsCentral Donney John said: "As an organization specifically built to aid people struggling to pay for their medication, it is an incredible opportunity to work with Lilly to bring insulin to those struggling with diabetes and the means to fight it."

"Lilly is committed to providing affordable insulin to people who need it ? including through our donations to relief agencies that supply free clinics across the U.S.," said Andy Vicari, senior director, insulins, Lilly and Company. "NOVA ScriptsCentral does a great job reaching people living with diabetes who need help, some of whom may have run out of options. With their help, more people are accessing the insulin they need."

About NOVA ScriptsCentral: Established in 2006, NovaScripts Central's mission is to provide quality integrated pharmaceutical care and medication access to the low-income uninsured children and adults of Northern Virginia. They are founded on the belief that all individuals should have access to quality healthcare regardless of where the care is being delivered.

 

SOURCE NOVA ScriptsCentral


These press releases may also interest you

at 13:12
By mid-March, the emerging pandemic sounded alarms at the highest levels and Germfree was being asked to provide biological containment laboratories - fast. Calls came in from public health labs and researchers across the globe who work to contain...

at 13:12
The U.S. Food and Drug Administration today approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with...

at 13:10
"Global Coronavirus COVID 19 Clinical Trials Insight 2020" Report Highlight:Read the full report: https://www.reportlinker.com/p05869027/?utm_source=PRN ? Number Of Drugs In Clinical Trials: >30 Drugs? Majority Of Drugs in Research Phase: > 15...

at 13:06
Diverse Ability organizations from across the province are working hard to keep their residents safe during the COVID-19 pandemic and to adjust to the restrictions imposed under the Public Health Act.  Through implementing best practice infection...

at 13:05
Forward, the preventive primary care practice combining top rated doctors and advanced medical technology, today announces the availability of rapid blood testing to screen for COVID-19 at clinics and drive-through sites nationwide. The test provides...

at 13:05
"Global Cancer Generics Market, Drug Dosage, Price & Opportunity Insight 2026" Report Highlights:Read the full report: https://www.reportlinker.com/p05868679/?utm_source=PRN ? Global Cancer Generics Market Trend Analysis? Global Cancer Generics...



News published on 27 february 2020 at 11:00 and distributed by: